Bought
Maintained
Sold
Other funds holding CVM
BIT
BFA
BAS
RCM
FNBT
VKH
UBS's CVM Position: Q3 2014 in Review
UBS increased its CEL-SCI Corp (CVM) stake by 78% in Q3 2014, buying an estimated $16.8K and bringing the position to 48 shares worth $32K. The position accounts for ﹤0.01% of the portfolio, ranked #7382.
UBS first reported a position in CVM in Q2 2013 and has held it in 6 quarters since. The position peaked at $33K in Q4 2013. 26 funds tracked by Wall St. Rank hold CVM as of Q3 2014.
- UBS held 48 shares of CEL-SCI Corp worth $32K as of Q3 2014.
- UBS bought 21 CEL-SCI Corp shares in Q3 2014, an estimated $16.8K.
- CEL-SCI Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #7382 holding.
- UBS first reported a position in CEL-SCI Corp in Q2 2013 and has held it in 6 quarters since.
- UBS's CEL-SCI Corp position peaked at $33K in Q4 2013.
- 26 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.